Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TNX-1500 by Tonix Pharmaceuticals Holding for Heart Transplant Rejection: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Heart Transplant Rejection. According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Sicca Syndrome (Sjogren): Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Sicca Syndrome (Sjogren). According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Kidney Transplant Rejection: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Kidney Transplant Rejection. According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Systemic Lupus Erythematosus: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Systemic Lupus Erythematosus. According to...
TNX-1500 by Tonix Pharmaceuticals Holding for Rheumatoid Arthritis: Likelihood of Approval
TNX-1500 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase I for Rheumatoid Arthritis. According to GlobalData,...
TNX-1900 by Tonix Pharmaceuticals Holding for Obesity: Likelihood of Approval
TNX-1900 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase II for Obesity. According to GlobalData, Phase...
TNX-1900 by Tonix Pharmaceuticals Holding for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
TNX-1900 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase II for Social Anxiety Disorder (SAD/Social Phobia)....
Tonmya by Tonix Pharmaceuticals Holding for Fibromyalgia (Fibromyalgia Syndrome): Likelihood of Approval
Tonmya is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase III for Fibromyalgia (Fibromyalgia Syndrome). According to...
TNX-1900 by Tonix Pharmaceuticals Holding for Autism Spectrum Disorder (ASD): Likelihood of Approval
TNX-1900 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase II for Autism Spectrum Disorder (ASD). According...
TNX-1900 by Tonix Pharmaceuticals Holding for Binge Eating Disorder: Likelihood of Approval
TNX-1900 is under clinical development by Tonix Pharmaceuticals Holding and currently in Phase II for Binge Eating Disorder. According to...